M&TF2024Wk1

Question 1

Prednisone (G)
B:
C: (class)
Indications:
F (formulations):
DR (dose range):
ADEs:

Answer 1

B: Deltasone

C: Corticosteroid

Indications:
Allergic, dermatological, endocrine, GI diseases, Hemtologic disorders, Neoplastic diseases, Nervous system(MS), Renal diseases (lupus), Rheumatic disorders (rheumatoid arthritis)

F: tablet, oral solution

DR: 5-60mg

ADE: AEIOU
A: Adrenal insufficiency agitation
E: eyes (ocular effects such as glaucoma) edema(weight gain)
I: Infection (from immunosuppresion) insomnia, increased appetite
O: osteoporosis
U: Ulcers and sometimes H: hyperglycemia, hypertension

Question 2

Methylprednisolone(G)
B:
C:
I:
F:
DR:
ADE:

Answer 2

B: Medrol(PO), SoluMedrol (IV)
C: Corticosteroid
I: Allergic, dermatological, endocrine, GI diseases, Hemtologic disorders, Neoplastic diseases, Nervous system(MS), Renal diseases (lupus), Rheumatic disorders (rheumatoid arthritis)
F: tablet, IV solution
DR: 4-48 mg more potent than prednisolone
ADE:

AEIOU
A: Adrenal insufficiency agitation
E: eyes (ocular effects such as glaucoma) edema(weight gain)
I: Infection (from immunosuppresion) insomnia, increased appetite
O: osteoporosis
U: Ulcers and sometimes H: hyperglycemia, hypertension

Question 3

Triamcinolone(G)
B:
C:
I:
F:
DR:
ADE:

Answer 3

B: Kenalog
C: topical corticosteroid
I: skin disorders
F: cream lotion, ointment, aerosol solution
DR: % strength of topical products ranges from 0.025-0.5%
ADE: Skin atrophy, hyper/hypo pigmentation

Question 4

Hydroxychloroquine(G)
B:
C:
I:
F:
DR:
ADE:

Answer 4

B: Plaquenil
C: Aminoquinoline
I: Lupus, malaria (prevention and treatment), rheumatoid arthritis
F: Tablet
DR: 200-600mg or 2g for malaria
ADE: Retinal toxicity

Question 5

Amoxicillin(G)
B:
C:
I: (bugs covered)
F:
DR:
ADE:

Answer 5

B: Amoxil, Moxatag
C: β-Lactam Antibiotic
I: Strep species (Stepococcus pneumonia) Enterococcus faecalis and some gram negatives such as E. coli
F: capsules, chewable tablet, suspension, tablet
DR: 500-1,500 mg
ADE: Hypersensitivity, GI upset

Question 6

Azithromycin(G)
B:
C:
I:
F:
DR:
ADE:

Answer 6

B: Zithromax, Z-Pak
C: Macrolide antibiotic
I: Strep species, Atypicals( legionella, mycoplasma pneumonia, chalmydophilia species), some gram negatives such as E. Coli
F: Tablet, suspension, packet
DR: 250-500mg
ADE: QT prolongation, Hypersensitivity, GI upset

Question 7

Trimethoprim (TMP)/ Sulfamethoxazole(SMZ)
B:
C:
I: (or coverage)
F:
DR:
ADE:

Answer 7

B: Bactrim, Septra
C: Sulfonamide Antibiotic
I: MRSA( methicillin resistant staphylococcus aureus) & MSSA (methicillin sensitive staphylococcus aureus) and GNRs (gram negative rods)
F: Tablet, suspension, IV solution (available as single strength and double strength tablets)
DR: 1-2 Double strength tabs every 1-2XD
ADE: Hypersensitivity (rash to Steven’s-Johnson Syndrome) renal failure, hyperkalemia

Question 8

Amoxicillin/Clavulanate
B:
C:
I:
F:
DR:
ADE:

Answer 8

B: Augmentin
C: β-lactate antibiotic
I: Anaerobes, MSSA, Strep, E. Faecalis, GNRs
F: tablet, XR tablet, tablet chewable, suspension
DR: 500-4000
ADE: Hypersensitivity, GI upset

Question 9

Ciprofloxacin
B:
C:
F:
DR:
ADE:
BLACK BOX WARNING:

Answer 9

B: Cipro, Cipro XR
C: Fluroquinolone antibiotic
I: GNRs, some P. Aeruginosa (such as pseudomonas), Atypicals
F: Oral suspension, oral tablet
DR: 500-1500 mg
ADE: QT prolongation, tendon rupture, glucose dysregulation, hypersensitivity
BB: irreversible serious adverse reactions such as tendinitis and tendon rupture, peripheral neuropathy, CNS effects

Question 10

Cephalexin

Answer 10

B: keflex, Daxbia
C: 1st-gen Cephalosporin
I: MSSA, Strep species, some GNRs
F: Oral suspension, tablet, capsule
DR: 250-2000mg
ADE: Hypersensitivity

Question 11

Prefix/Suffi/Root/Terms:
Rhabdo(o)-
Meg(a)-, megal(o)-, megaly -
Cyst(o)-
Scler(o)-
Psor-
Carcin(o)-

Answer 11

Rhabdo(o)- Striated skeletal muscle
Meg(a)-, megal(o)-, megaly - abnormally large
Cyst(o)- bladder sac or cyst
Scler(o)- hardening
Psor- itching
Carcin(o)- cancerous cancer